Nrf2 activation confers resistance to eif4a inhibitors in cancer therapy

Viraj R. Sanghvi, Prathibha Mohan, Kamini Singh, Linlin Cao, Marjan Berishaj, Andrew L. Wolfe, Jonathan H. Schatz, Nathalie Lailler, Elisa de Stanchina, Agnes Viale, Hans Guido Wendel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nrf2 activation confers resistance to eif4a inhibitors in cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences